PAPIVAX BIOTECH INC.
Update：2026/11/10
Industries
Main Industry
Biotechnology
Main Product/Service
Nexuni’s offerings include AI-powered smart parking systems (license-plate recognition, occupancy detection), smart security systems (facial recognition access control, patrol robots), facility management, factory automation, and unmanned store/retail aut
The content above was translated by Ai
Founded Year
2013
Unified Business No.
54188430
Status
Active
Number of Employees
9
Total Paid-in
Capital
692,870,000 (NT$)
Location of Company
Taiwan
, Taipei City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
PapiVax Biotech, Inc., founded in 2013 and headquartered in Taipei with a subsidiary in the United States, is a biotech company specializing in nucleic‑acid immunotherapy using proprietary DNA‑plasmid vector and delivery platforms — aiming to become a global leader in treating chronic viral infections and associated cancers.
The content above was translated by Ai
